Academy Capital Management’s Novo Nordisk NVO Stock Holding History

Academy Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23M	Sell	479,184 -240,046	-33%	-$10.3M	3.04%	13
2026 Q1	$26.4M	Buy	719,230 +353,447	+97%	+$16.7M	3.78%	12
2025 Q4	$18.6M	Sell	365,783 -1,636	-0.4%	-$83.7K	2.47%	14
2025 Q3	$20.4M	Buy	367,419 +1,170	+0.3%	+$68.5K	2.91%	13
2025 Q2	$25.3M	Sell	366,249 -1,325	-0.4%	-$90.1K	3.61%	12
2025 Q1	$25.5M	Buy	367,574 +213,453	+138%	+$17.6M	4.4%	11
2024 Q4	$13.3M	Buy	+154,121	New	+$16.7M	2.17%	13

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Academy Capital Management's NVO Position: Q2 2026 in Review

Academy Capital Management reduced its Novo Nordisk (NVO) stake by 33% in Q2 2026, selling an estimated $10.3M and leaving 479,184 shares worth $23M. The position accounts for 3.04% of the portfolio, ranked #13.

Academy Capital Management first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $26.4M in Q1 2026. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Academy Capital Management held 479,184 shares of Novo Nordisk worth $23M as of Q2 2026.
Academy Capital Management sold 240,046 Novo Nordisk shares in Q2 2026, an estimated $10.3M.
Novo Nordisk made up 3.04% of Academy Capital Management's portfolio in Q2 2026, its #13 holding.
Academy Capital Management first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
Academy Capital Management's Novo Nordisk position peaked at $26.4M in Q1 2026.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Academy Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.